Immunomodulatory Mechanism of Coronary Heart Disease and Related Therapeutic Applications and Prospects
DOI:
https://doi.org/10.54097/jqnqmf85Keywords:
Coronary heart disease, immune factors, treatment.Abstract
Coronary heart disease is a type of heart disease caused by stenosis or occlusion of the coronary artery lumen. The typical symptoms are chest pain, chest tightness, and aggravation after activity. It is divided into two categories, chronic coronary disease (CAD) and acute coronary syndrome (ACS). The pathological basis of CHD is coronary atherosclerosis, immune factors (cellular immunity, humoral immunity, autoimmunity, complement system, cytokines, adhesion molecules and apoptosis, etc.) are involved in the formation and development of atherosclerosis. So far, its pathogenesis has not been fully understood and there is no effective and specific drug treatment in clinic. This article is based on existing literature and research on the impact of immune regulation on coronary heart disease. To investigate the role of the immune system in the treatment of atherosclerosis, we analyzed the causes of atherosclerosis. Through literature search, this paper found the influence of infectious, autoimmune and chemical factors on atherosclerosis, and sought corresponding treatment methods for the cardiovascular and cerebrovascular injuries caused by these factors.
Downloads
References
Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005 Apr 21; 352(16): 1685-95.
Moreira DM, da Silva RL, Vieira JL, Fattah T, Lueneberg ME, Gottschall CA. Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease. Am J Cardiovasc Drugs. 2015 Feb; 15(1): 1-11.
Jun-tian liu. The research progress of inflammation mechanism of pathogenesis of atherosclerosis [J]. Journal of xi'an jiaotong university, medical sciences, 2015, 36 (2): 12.
Yang Weihua, ZHOU Jingqun, Zhu Ping. Immunoregulatory effects of coronary heart disease (CHD) of the current treatment [J]. Journal of cardio vascular disease, 2005, 24 (1): 55 to 57.
Hong Li, Zhang Li. Research progress on the mechanism of Chlamydia pneumoniae infection in different stages of atherosclerosis [J]. Chinese Journal of Arteriosclerosis, 2008, 16(12): 996-998.
Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis. 1993 Apr; 167(4): 841-9.
Shrestha S, Irvin MR, Grunfeld C, Arnett DK. HIV, inflammation, and calcium in atherosclerosis. Arterioscler Thromb Vasc Biol. 2014 Feb; 34(2): 244-50.
Mondal P, Aljizeeri A, Small G, Malhotra S, Harikrishnan P, Affandi JS, Buechel RR, Dwivedi G, Al-Mallah MH, Jain D. Coronary artery disease in patients with human immunodeficiency virus infection. J Nucl Cardiol. 2021 Apr; 28(2): 510-530.
Azithromycin therapy in patients with chronic Chlamydia pneumoniae infection and coronary heart disease: immediate and long-term effects on inflammation, coagulation, and lipid status in a double-blind, placebo-controlled study.
Recommendations for the management of cardiovascular disease risk factors associated with human immunodeficiency virus infection Chinese Journal of Infectious Diseases2020, 38(2): 72-79.
Sun DM, Ding Y, Zhnag Y, Xia K. [Serum lipid profile in children with different subtypes of juvenile idiopathic arthritis]. Zhongguo Dang Dai Er Ke Za Zhi. 2019 Jun; 21(6): 547-551. Chinese.
Pan G, Fan Y. [Progress of Steroids Effect on Efficacy of Immune Checkpoint Inhibitors]. Zhongguo Fei Ai Za Zhi. 2019 Dec 20; 22(12): 786-793. Chinese.
Alfaro S, Acuña V, Ceriani R, Cavieres MF, Weinstein-Oppenheimer CR, Campos-Estrada C. Involvement of Inflammation and Its Resolution in Disease and Therapeutics. Int J Mol Sci. 2022 Sep 14; 23(18): 10719.
Smith J, Doe J, Johnson M. The role of regulatory T cells in coronary artery disease: Induction and therapy. Pharmacol Ther. 2018; 184: 41-49.
Jones L, Nguyen H, Lee J, et al. Immunomodulatory Effects of Therapeutic Hypothermia on Inflammatory Response Following Acute Myocardial Infarction. J Cardiovasc Pharmacol Ther. 2019; 24(5): 456-464.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
